We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$2.54B
Cap. Flow
% of AUM
3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.91% |
| 2 | Technology | 16.4% |
| 3 | Healthcare | 13.22% |
| 4 | Consumer Discretionary | 12.71% |
| 5 | Financials | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Dick's Sporting Goods
DKS
$11.8B
| $85.8M | 0.13% |
+381,661
| New | +$65.2M |
|
152
XP
XP
$10.1B
| $85.8M | 0.13% |
3,343,807
+725,664
| +28% | +$18.2M |
|
153
PUT
Pfizer
PFE
$158B
| $85.1M | 0.13% |
+3,000,000
| New | +$83.2M |
|
154
PUT
Citigroup
C
$229B
| $84.6M | 0.13% |
1,331,100
+1,131,900
| +568% | +$63M |
|
155
General Motors
GM
$75.3B
| $84.4M | 0.13% |
1,860,655
+1,045,523
| +128% | +$40.5M |
|
156
TransUnion
TRU
$14.9B
| $83.3M | 0.13% |
1,043,722
-224,839
| -18% | -$16.5M |
|
157
Martin Marietta Materials
MLM
$36.4B
| $82.8M | 0.13% |
134,932
+87,012
| +182% | +$47.5M |
|
158
Robinhood
HOOD
$105B
| $82.3M | 0.13% |
4,087,443
+677,530
| +20% | +$9.5M |
|
159
HubSpot
HUBS
$12B
| $80.2M | 0.12% |
+128,002
| New | +$76.9M |
|
160
Assured Guaranty
AGO
$3.21B
| $79.3M | 0.12% |
+909,204
| New | +$76.6M |
|
161
PUT
NVIDIA
NVDA
$5.45T
| $78.4M | 0.12% |
858,000
-1,182,000
| -58% | -$85.7M |
|
162
Vertex Pharmaceuticals
VRTX
$134B
| $78.2M | 0.12% |
187,139
-91,191
| -33% | -$38.6M |
|
163
Quest Diagnostics
DGX
$26B
| $78M | 0.12% |
586,199
+417,862
| +248% | +$54.2M |
|
164
MINISO
MNSO
$2.8B
| $77.9M | 0.12% |
3,798,327
+769,811
| +25% | +$14.7M |
|
165
AstraZeneca
AZN
$248B
| $77.6M | 0.12% |
572,819
+552,432
| +2,710% | +$73.2M |
|
166
PUT
UnitedHealth
UNH
$360B
| $77.1M | 0.12% |
150,000
+129,000
| +614% | +$65.6M |
|
167
Progressive
PGR
$125B
| $76.6M | 0.12% |
370,329
+364,429
| +6,177% | +$67.6M |
|
168
Trade Desk
TTD
$6.59B
| $76.1M | 0.12% |
870,814
+403,018
| +86% | +$30.5M |
|
|
BNY
169
Bank of New York Mellon
BNY
$110B
| $76M | 0.12% |
1,319,244
-139,457
| -10% | -$7.68M |
|
170
T. Rowe Price
TROW
$23.3B
| $75M | 0.11% |
614,923
-456,456
| -43% | -$51M |
|
|
CYBR
171
DELISTED
CyberArk
CYBR
| $74.6M | 0.11% |
280,655
+203,256
| +263% | +$50.3M |
|
|
172
Walmart Inc
WMT
$841B
| $74M | 0.11% |
1,229,277
-6,986,535
| -85% | -$400M |
|
173
Tesla
TSLA
$1.45T
| $73.9M | 0.11% |
420,374
-911,554
| -68% | -$178M |
|
174
Five Below
FIVE
$14B
| $72.3M | 0.11% |
398,620
-361,909
| -48% | -$69.7M |
|
175
Freshpet
FRPT
$3.23B
| $72.3M | 0.11% |
623,827
-114,795
| -16% | -$11.1M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace deployed $2.54B of net new capital in Q1 2024, opening 828 new positions and adding to 695 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Walmart Inc, an estimated $400M trimmed.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.